Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Lisbeth M. Baggesen"'
Autor:
Reimar W. Thomsen, Jakob S. Knudsen, Johnny Kahlert, Lisbeth M. Baggesen, Maria Lajer, Pia H. Holmgaard, Ola Vedin, Anastasia Ustyugova, Henrik T. Sørensen
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 11 (2021)
Background In cardiovascular outcome trials, the sodium glucose cotransporter 2 inhibitor empagliflozin and glucagon‐like peptide‐1 (GLP‐1) receptor agonist liraglutide caused similar reductions in major adverse cardiac events (MACE). We compar
Externí odkaz:
https://doaj.org/article/4eca55072e3d480ea3232432235fc9da
Autor:
Jakob S Knudsen, Lisbeth M Baggesen, Maria Lajer, Larisa Nurkanovic, Anastasia Ustyugova, Henrik T Sørensen, Reimar W Thomsen
Publikováno v:
PLoS ONE, Vol 15, Iss 3, p e0229621 (2020)
BACKGROUND:We investigated changes in clinical characteristics of SGLT2i and GLP-1RA real-world initiators in Denmark before/after landmark cardiovascular outcome trials. METHODS:We compared first-time SGLT2i (25,070) and GLP-1RA (14,671) initiators
Externí odkaz:
https://doaj.org/article/d2660ea33cda4aa098d1d41a859e8989
Autor:
Maria Lajer, Reimar W. Thomsen, Lisbeth M. Baggesen, Pia H. Holmgaard, Ola Vedin, Anastasia Ustyugova, Henrik Toft Sørensen, Jakob S. Knudsen, Johnny Kahlert
Publikováno v:
Thomsen, R W, Knudsen, J S, Kahlert, J, Baggesen, L M, Lajer, M, Holmgaard, P H, Vedin, O, Ustyugova, A & Sørensen, H T 2021, ' Cardiovascular events, acute hospitalizations, and mortality in patients with type 2 diabetes mellitus who initiate empagliflozin versus liraglutide : A comparative effectiveness study ', Journal of the American Heart Association, vol. 10, no. 11, e019356 . https://doi.org/10.1161/JAHA.120.019356
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 11 (2021)
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 11 (2021)
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background In cardiovascular outcome trials, the sodium glucose cotransporter 2 inhibitor empagliflozin and glucagon‐like peptide‐1 (GLP‐1) receptor agonist liraglutide caused similar reductions in major adverse cardiac events (MACE). We compar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f9e6708137f465c2faae4392bb04b6a
https://pure.au.dk/portal/da/publications/cardiovascular-events-acute-hospitalizations-and-mortality-in-patients-with-type-2-diabetes-mellitus-who-initiate-empagliflozin-versus-liraglutide(7a67d7d5-f317-4167-83c9-a42a2d571bd8).html
https://pure.au.dk/portal/da/publications/cardiovascular-events-acute-hospitalizations-and-mortality-in-patients-with-type-2-diabetes-mellitus-who-initiate-empagliflozin-versus-liraglutide(7a67d7d5-f317-4167-83c9-a42a2d571bd8).html
Autor:
E. S. Buhl, Reimar W. Thomsen, Helene Nørrelund, Lars Pedersen, Elisabeth Svensson, Lisbeth M. Baggesen, Søren Paaske Johnsen, Christiane L Haase
Publikováno v:
Svensson, E, Baggesen, L M, Johnsen, S P, Pedersen, L, Nørrelund, H W, Buhl, E S, Haase, C L & Thomsen, RW 2017, ' Early Glycemic Control and Magnitude of HbA1c Reduction Predict Cardiovascular Events and Mortality : Population-Based Cohort Study of 24,752 Metformin Initiators ', Diabetes Care, vol. 40, no. 6, pp. 800-807 . https://doi.org/10.2337/dc16-2271
OBJECTIVE We investigated the association of early achieved HbA1c level and magnitude of HbA1c reduction with subsequent risk of cardiovascular events or death in patients with type 2 diabetes who initiate metformin. RESEARCH DESIGN AND METHODS This
Autor:
Reimar W. Thomsen, Larisa Nurkanovic, Anastasia Ustyugova, Henrik Toft Sørensen, Maria Lajer, Jakob S. Knudsen, Lisbeth M. Baggesen
Publikováno v:
Diabetes. 68
Objectives: To investigate changes in clinical characteristics of SGLT2i and GLP-1RA initiators in Denmark before/after landmark trials. Materials and Methods: Compared first-time SGLT2i (25,070) and GLP-1RA (15,803) initiators to initiators of DPP-4
Autor:
Reimar W. Thomsen, Maria Lajer, Lisbeth M. Baggesen, Larisa Nurkanovic, Anastasia Ustyugova, Henrik Toft Sørensen, Jakob S. Knudsen
Publikováno v:
PLoS ONE, Vol 15, Iss 3, p e0229621 (2020)
Knudsen, J S, Baggesen, L M, Lajer, M, Nurkanovic, L, Ustyugova, A, Sørensen, H T & Thomsen, R W 2020, ' Changes in SGLT2i and GLP-1RA real-world initiator profiles following cardiovascular outcome trials : A Danish nationwide population-based study ', PLOS ONE, vol. 15, no. 3, e0229621 . https://doi.org/10.1371/journal.pone.0229621
PLoS ONE
Knudsen, J S, Baggesen, L M, Lajer, M, Nurkanovic, L, Ustyugova, A, Sørensen, H T & Thomsen, R W 2020, ' Changes in SGLT2i and GLP-1RA real-world initiator profiles following cardiovascular outcome trials : A Danish nationwide population-based study ', PLOS ONE, vol. 15, no. 3, e0229621 . https://doi.org/10.1371/journal.pone.0229621
PLoS ONE
Background: We investigated changes in clinical characteristics of SGLT2i and GLP-1RA real-world initiators in Denmark before/after landmark cardiovascular outcome trials. Methods: We compared first-time SGLT2i (25,070) and GLP-1RA (14,671) initiator
Publikováno v:
Madsen, L R, Baggesen, L M, Richelsen, B & Thomsen, R W 2019, ' Effect of Roux-en-Y gastric bypass surgery on diabetes remission and complications in individuals with type 2 diabetes: a Danish population-based matched cohort study ', Diabetologia, vol. 62, no. 4, pp. 611-620 . https://doi.org/10.1007/s00125-019-4816-2
AIMS/HYPOTHESIS: The aim of this study was to examine the effect of Roux-en-Y gastric bypass (RYGB) surgery on diabetes remission, subsequent diabetes relapse and micro- and macrovascular complications in individuals with type 2 diabetes and obesity
Autor:
M. Maria Glymour, Sigrún Alba Jóhannesdóttir Schmidt, Vera Ehrenstein, Mathias Lasgaard, Arnold Milstein, Henrik Toft Sørensen, Kristina Laugesen, Nancy E. Adler, Lisbeth M. Baggesen
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-8 (2018)
Scientific reports, vol 8, iss 1
Laugesen, K, Baggesen, L M, Schmidt, S A J, Glymour, M M, Lasgaard, M, Milstein, A, Sørensen, H T, Adler, N E & Ehrenstein, V 2018, ' Social isolation and all-cause mortality : a population-based cohort study in Denmark ', Scientific Reports, vol. 8, 4731 . https://doi.org/10.1038/s41598-018-22963-w
Laugesen, K, Baggesen, L M, Schmidt, S A J, Glymour, M M, Lasgaard, M, Milstein, A, Sørensen, H T, Adler, N E & Ehrenstein, V 2018, ' Social isolation and all-cause mortality : a population-based cohort study in Denmark ', Scientific Reports, vol. 8, no. 1, 4731 . https://doi.org/10.1038/s41598-018-22963-w
Scientific Reports
Scientific reports, vol 8, iss 1
Laugesen, K, Baggesen, L M, Schmidt, S A J, Glymour, M M, Lasgaard, M, Milstein, A, Sørensen, H T, Adler, N E & Ehrenstein, V 2018, ' Social isolation and all-cause mortality : a population-based cohort study in Denmark ', Scientific Reports, vol. 8, 4731 . https://doi.org/10.1038/s41598-018-22963-w
Laugesen, K, Baggesen, L M, Schmidt, S A J, Glymour, M M, Lasgaard, M, Milstein, A, Sørensen, H T, Adler, N E & Ehrenstein, V 2018, ' Social isolation and all-cause mortality : a population-based cohort study in Denmark ', Scientific Reports, vol. 8, no. 1, 4731 . https://doi.org/10.1038/s41598-018-22963-w
Scientific Reports
Social isolation is associated with increased mortality. Meta-analytic results, however, indicate heterogeneity in effect sizes. We aimed to provide new evidence to the association between social isolation and mortality by conducting a population-bas
Autor:
Thor Ameri Chalmer, Mette Nørgaard, Lisbeth M. Baggesen, Melinda Magyari, Per Soelberg Sørensen, Nils Koch-Henriksen
Publikováno v:
Chalmer, T A, Baggesen, L M, Nørgaard, M, Koch-Henriksen, N, Magyari, M, Sorensen, P S & Danish Multiple Sclerosis Group 2018, ' Early versus later treatment start in multiple sclerosis. a register-based cohort study ', European Journal of Neurology, vol. 25, no. 10, pp. 1262-e110 . https://doi.org/10.1111/ene.13692
BACKGROUND AND PURPOSE: To assess long-term treatment effectiveness of disease-modifying therapy (DMT) initiated early in disease course versus later treatment start.METHODS: We included all Danish patients with multiple sclerosis (MS) treated with D
Autor:
Henrik Carl Schønheyder, Lisbeth M. Baggesen, Sigrún Alba Jóhannesdóttir Schmidt, Henrik Toft Sørensen, Mogens Vestergaard, Lars Pedersen
Publikováno v:
Schmidt, S A J, Vestergaard, M, Baggesen, L M, Pedersen, L, Schønheyder, H C & Sørensen, H T 2017, ' Prevaccination epidemiology of herpes zoster in Denmark : Quantification of occurrence and risk factors ', Vaccine, vol. 35, no. 42, pp. 5589-5596 . https://doi.org/10.1016/j.vaccine.2017.08.065
Background Herpes zoster (HZ) is a vaccine-preventable disease caused by reactivation of the varicella-zoster virus. Unfortunately, formulation of recommendations on routine immunization is hampered by a lack of data on disease burden, since most cou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d79420cd8f2e806808f2c88b9ea85e8d
https://pure.au.dk/portal/da/publications/prevaccination-epidemiology-of-herpes-zoster-in-denmark(01a2cc90-249c-4447-97a0-ebf3ba3a59d7).html
https://pure.au.dk/portal/da/publications/prevaccination-epidemiology-of-herpes-zoster-in-denmark(01a2cc90-249c-4447-97a0-ebf3ba3a59d7).html